Innovative AI Tool Accelerates and Enhances Diagnosis of Endocrine Cancers
A novel AI-powered application is revolutionizing the detection of endocrine cancers, offering faster and more accurate diagnoses globally, including on basic devices like smartphones.
A groundbreaking artificial intelligence (AI) application is set to transform the diagnosis of endocrine cancers by enabling healthcare professionals to identify these complex malignancies more rapidly and with greater precision. Demonstrated at the upcoming ENDO 2025 conference in San Francisco, this publicly accessible AI system leverages advanced deep learning architectures such as EfficientNet and ResNet to analyze a variety of medical imaging data, including CT scans, MRI, ultrasonography, and histopathology images.
Developed by researchers led by Jansi Rani Sethuraj from the University of Texas Health Science Center, the tool is designed to democratize expert-level diagnostics. It can be utilized on basic internet-connected devices like smartphones, ensuring wider availability, especially in resource-limited settings. The AI models exhibited diagnostic accuracies exceeding 99% in validation tests across various endocrine cancer types affecting organs such as the thyroid, ovaries, pancreas, pituitary, and adrenal glands.
This innovation results from a collaborative effort involving the curating of diverse, anonymized datasets from six continents by researchers Ramya and Kavin Elangovan of AIM Doctor in Houston. The application’s rapid processing capability—analyzing each image in less than a second—makes it highly practical for real-time clinical decision-making.
Global healthcare professionals have assessed the system's performance and usability, confirming its potential for widespread clinical adoption. By providing swift and reliable diagnostic support, this AI tool promises to reduce errors, accelerate treatment planning, and ultimately improve patient outcomes. As emphasized by project lead Elangovan Krishnan, this technology represents a significant stride toward equitable access to cutting-edge cancer diagnostics worldwide.
This initiative underscores the importance of scalable solutions in fighting endocrine cancers, which cause millions of deaths annually, by making advanced diagnostics more accessible and efficient for clinicians around the globe.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Rethinking the Necessity of Six-Monthly Dental Check-Ups and Cleanings
Recent research indicates that routine dental check-ups every six months may not be necessary for everyone. Tailoring visit frequency based on individual risk factors can better support oral health and resource efficiency.
Research Demonstrates HPV Vaccine Offers Protection to Both Vaccinated and Unvaccinated Women
A landmark study shows HPV vaccination not only protects vaccinated women but also provides herd immunity benefits to unvaccinated populations, reducing HPV infection rates significantly and supporting efforts to eliminate cervical cancer worldwide.
Understanding Late-Life Virginity: Insights into Genetic, Psychological, and Social Factors
A groundbreaking study explores the multifaceted factors behind late-life virginity, revealing genetic, psychological, and social influences impacting adults who have never had sex.
Study Finds Buprenorphine During Pregnancy Reduces Preterm Birth and Long-Term Costs for Mothers and Infants with Opioid Use Disorder
Research shows that buprenorphine treatment during pregnancy improves health outcomes for mothers and infants with opioid use disorder and results in significant long-term cost savings.